Donald Trump is likely to soon nominate Scott Gottlieb, a physician and policy expert at the American Enterprise Institute, as the next commissioner at the Food and Drug Administration. Gottlieb edged out Jim O'Neill, a libertarian venture capitalist backed by billionaire investor Peter Thiel, for the nod. As Gottlieb prepares for the his Senate confirmation hearings, there's likely to be lots of interest in his public thoughts on healthcare. Here at Forbes, we've been lucky to count Scott among our contributors for many years. Patients Will Feel The EffectsThis is the paradigmatic Gottlieb post: a small, seemingly mind-numbing change in the rules around diagnostic tests was affecting patients.

Source: Forbes March 10, 2017 21:17 UTC